Amedisys Stock Options Expiring on 21st of March
| AMED Stock | USD 91.79 0.51 0.56% |
Amedisys' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 0.12. The total put volume is at 2.0, with calls trading at the volume of 3.0. This yields a 0.67 put-to-call volume ratio. The Amedisys option chain provides detailed quote and price information for the current Amedisys option contracts. It shows all of Amedisys' listed puts, calls, expiration dates, strike prices, and other pricing information.
Amedisys Maximum Pain Price Across 2025-03-21 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Amedisys close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Amedisys' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Amedisys' stock options are financial instruments that give investors the right to buy or sell shares of Amedisys common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Amedisys stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Amedisys' stock price goes up or down, the stock options follow.
At present, Amedisys' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. Amedisys Current Options Market Mood
Amedisys' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Amedisys Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Amedisys' options investors are not very successful. Amedisys' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Amedisys contract
Base on the Rule 16, the options market is currently suggesting that Amedisys will have an average daily up or down price movement of about 0.0075% per day over the life of the 2025-03-21 option contract. With Amedisys trading at USD 91.79, that is roughly USD 0.006884. If you think that the market is fully incorporating Amedisys' daily price movement you should consider buying Amedisys options at the current volatility level of 0.12%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Amedisys |
Amedisys Option Chain
When Amedisys' strike price is surpassing the current stock price, the option contract against Amedisys stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Amedisys' option chain is a display of a range of information that helps investors for ways to trade options on Amedisys. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Amedisys. It also shows strike prices and maturity days for a Amedisys against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | AMED250321C00055000 | 0 | 55.0 | 40.1 - 45.0 | 40.1 | |
Call | AMED250321C00060000 | 0 | 60.0 | 35.2 - 40.0 | 35.2 | |
Call | AMED250321C00065000 | 0 | 65.0 | 30.6 - 35.5 | 30.6 | |
Call | AMED250321C00070000 | 0 | 70.0 | 25.5 - 30.4 | 25.5 | |
Call | AMED250321C00075000 | 0 | 75.0 | 21.2 - 25.5 | 21.2 | |
Call | AMED250321C00080000 | 0 | 80.0 | 16.0 - 20.5 | 18.6 | |
Call | AMED250321C00085000 | 0 | 85.0 | 11.9 - 15.5 | 11.9 | |
Call | AMED250321C00090000 | 0 | 90.0 | 7.4 - 11.0 | 9.8 | |
Call | AMED250321C00095000 | 0 | 95.0 | 3.3 - 7.0 | 4.6 | |
Call | AMED250321C00100000 | 0 | 100.0 | 0.1 - 3.8 | 0.1 | |
Put | AMED250321P00055000 | 0 | 55.0 | 0.0 - 2.2 | 2.2 | |
Put | AMED250321P00060000 | 0 | 60.0 | 0.0 - 2.2 | 2.2 | |
Put | AMED250321P00065000 | 0 | 65.0 | 0.0 - 2.25 | 2.25 | |
Put | AMED250321P00070000 | 0 | 70.0 | 0.0 - 2.35 | 2.35 | |
Put | AMED250321P00075000 | 0 | 75.0 | 0.0 - 2.45 | 2.45 | |
Put | AMED250321P00080000 | 0 | 80.0 | 0.0 - 2.7 | 2.7 | |
Put | AMED250321P00085000 | 0 | 85.0 | 0.0 - 3.1 | 3.1 | |
Put | AMED250321P00090000 | 0 | 90.0 | 0.1 - 3.8 | 0.1 | |
Put | AMED250321P00095000 | 0 | 95.0 | 0.45 - 4.5 | 0.45 | |
Put | AMED250321P00100000 | 0 | 100.0 | 1.8 - 5.0 | 4.7 |
Amedisys Market Cap Over Time
Market Cap |
| Timeline |
Amedisys Total Stockholder Equity
Total Stockholder Equity |
|
Amedisys Corporate Management
| John Nugent | Chief Officer | Profile | |
| Pete Hartley | CTO Systems | Profile | |
| Kendra Kimmons | VP Relations | Profile | |
| Jennifer Griffin | Chief Secretary | Profile | |
| Janet Britt | VP Collections | Profile | |
| Francis Mayer | Senior Development | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.35) | Earnings Share 2.52 | Revenue Per Share | Quarterly Revenue Growth 0.057 | Return On Assets |
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.